Skip to main content
Clinical Trials/CTRI/2024/05/067265
CTRI/2024/05/067265Not yet recruitingPhase 3

A Randomised controlled trail to evaluate the efficacy of Ayurveda Intervention (Nitya Virechana)as an add-on to Standard Care in Secondary Hyperlipidemia. - Nil

andini RD0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •1.Patients of all genders between the age group of 20-65 years who fulfil the criteria of Objective and Subjective parameters.
  • •2.Controlled HTN -less than or equal to 140/90 mm of Hg.
  • •3.Controlled NIDDM -HbA1C less than or equal to 7%.
  • •4.Patients fulfilling the diagnostic criteria of Hyperlipidaemia.
  • •5.Patients already on Antilipidemic drugs since 0-10years.
  • •6.Patients fit for Nitya Virechana.

Exclusion Criteria

  • •1.Patients newly diagnosed and not on Antilipidemic drugs.
  • •2.Induced Hyperlipidaemia due to prolonged intake of Glucocortiosteriods.
  • •3.Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Tuberculosis, Psycho-Neuro-Endocrinal disorders, CKD, Nephrotic Syndrome, Liver disorders etc.)
  • •4.Patients with a past history of Atrial Fibrillation, Acute Coronary Syndrome,
  • •5.Patient with evidence of malignancy.
  • •6.Pregnant and lactating women.

Investigators

Sponsor
andini RD

Similar Trials